We studied the effect of leukotriene D 4 (LTD 4 ) on a human bronchial epithelial cell line (16HBE) overexpressing the cysteinyl leukotriene (CysLT) 1 receptor (HBECysLT 1 R), looking at the associated signal transduction mechanisms as well as at effects on inflammatory cell adhesion. The results obtained showed that LTD 4 increases the phosphorylation of extracellular signal-regulated protein kinase (ERK) 1/2 and of the signal transducer and activator of transcription 1 (STAT-1) in serine 727 (STAT-1Ser727), resulting in increased eosinophil adhesion to HBECysLT 1 R, associated with enhanced surface expression of intercellular adhesion molecule (ICAM) 1. Pretreatment with a CysLT 1 R-selective antagonist or with a selective inhibitor of protein kinase C (PKC) or with a selective inhibitor of the mitogen-activated protein kinase kinase (MEK) successfully suppressed both LTD 4 -induced STAT-1Ser727 phosphorylation and the associated increase in eosinophil adhesion. The use of the MEK inhibitor and of the selective CysLT 1 R antagonist in electrophoretic mobility shift assay experiments showed that LTD 4 promotes the nuclear translocation of STAT-1 through the activation of ERK1/2 pathway. The key role of STAT-1 in leukotriene D 4 transduction signaling was confirmed by RNA interference experiments, where silencing of STAT-1 expression abolished the effect of leukotriene D 4 on eosinophil adhesion. In conclusion, for the first time, we provide evidence of the involvement of STAT-1 in the signal transduction mechanism of the CysLT 1 receptor; phosphorylation of STAT-1, through PKC and ERK1/2 activation, causes enhanced ICAM-1 surface expression and eosinophil adhesion. Effective CysLT 1 R antagonism may therefore contribute to the control of the chronic inflammatory condition that characterizes human airways in asthma.Cysteinyl leukotrienes (CysLTs) play an important role in the pathogenesis of airway inflammation and remodeling in asthma (Drazen, 1998;Bisgaard, 2000;Henderson et al., 2002). The biological effects of CysLTs are mediated by at least two G protein-coupled receptors (GPCRs), namely cysteinyl leukotrienes receptor 1 (CysLT 1 R) and receptor 2, and the CysLT 1 R is known to be involved in most of the biological effects in the lung (Nicosia et al., 1999;Dahlén, 2000). CysLT 1 R is expressed in smooth muscle cells and lung macrophages (Lynch et al., 1999) and is widely distributed in human eosinophils, monocytes, and neutrophils (Figueroa et al., 2001;Mita et al., 2001); little is known about the expression and the responses of CysLT 1 R in the airway epithelium, but recent evidence showed that LTC 4 may elicit transformThis study was supported in part by the European Community VIth Framework Program (Grant LSHM CT 2004 005033; to A.S.)